Back to Search Start Over

A Prospective, Randomized, Multicenter Study Comparing Silicated Calcium Phosphate versus BMP-2 Synthetic Bone Graft in Posterolateral Instrumented Lumbar Fusion for Degenerative Spinal Disorders.

Authors :
Coughlan, Marc
Davies, Mark
Mostert, Adriaan K.
Nanda, Dharmin
Willems, Paul C.
Rosenberg, Geoffrey
Ferch, Richard
Source :
Spine (03622436). 8/1/2018, Vol. 43 Issue 15, pE860-E868. 1p.
Publication Year :
2018

Abstract

<bold>Study Design: </bold>A prospective, Phase IV, multicenter, randomized study.<bold>Objective: </bold>The aim of this study was to compare vertebral fusion success rates following posterolateral fusion [(PLF)/posterolateral intertransverse fusion (PITF)] surgery. The surgical procedure combined posterior lumbar interbody fusion (PLIF) and PLF with internal fixation over one or two levels using silicated calcium phosphate (SiCaP) or bone morphogenetic protein (BMP)-2 as graft material in patients with a degenerative disorder of the lumbar spine.<bold>Summary Of Background Data: </bold>Few controlled trials have evaluated the bone graft materials available to surgeons treating patients with spinal disorders, including degenerative disc disease, spondylolisthesis, and disc herniation.<bold>Methods: </bold>Following randomization, the surgical procedure consisting of PLIF and PLF with internal fixation over one or two levels was performed using SiCaP or BMP-2. No other osteoconductive/osteoinductive graft materials were permitted. Spinal fusion was assessed radiographically at ≤24 months. Clinical outcomes (pain on visual analog scale, Oswestry Disability Index, SF-36) and adverse events (AEs) were monitored.<bold>Results: </bold>One hundred three patients were enrolled. At 12 months, fusion was achieved in 25 of 35 (71.4%) of the SiCaP and 20 of 27 (74.1%) of the BMP-2 group, respectively (P = 1.000). At 24 months, the fusion rate was 78.6% and 84.8% for SiCaP and BMP-2, respectively (P = 0.5613). Clinical outcomes improved similarly in both groups over time. AEs were consistent with this surgical population.<bold>Conclusion: </bold>SiCaP was safe and well tolerated in patients with degenerative spinal disorders requiring PLF and provided fusion rates similar to BMP-2.<bold>Level Of Evidence: </bold>2. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03622436
Volume :
43
Issue :
15
Database :
Academic Search Index
Journal :
Spine (03622436)
Publication Type :
Academic Journal
Accession number :
130742639
Full Text :
https://doi.org/10.1097/BRS.0000000000002678